Search results for Big Pharma

<![CDATA[What's Driving the Concentration of Blockbuster Drugs]]>

Pharma Companies Invest In US While India Still Depends On China For APIs

“For decades, India built its reputation as the “pharmacy of the world” by manufacturing low-cost generic medicines that reached millions across Africa, Latin America, and Asia. Bu...

All Major Pharma Companies Implicated in Bribery Schemes, New Report Says

Pfizer, J&J, Eli Lilly, BMS, AstraZeneca, GSK, and more all engaged in systematic bribery schemes, according to decades of OECD reports. That’s the finding of a bombshell new s...

Indian Pharma Majors Plan to Invest in US

The United States is the biggest market for Indian generic drug products by sales

<![CDATA[Strengthening the Generic Drugs Supply Chain]]>

<![CDATA[Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement]...

Research Reveals Pharma Profits Outweigh Anti-Kickback Penalties

The pharmaceutical industry has a well documented history of corruption and placing profit above public health. A new research letter published in JAMA Open finds that US revenues...

The Truth About 340B - and Why Drug Companies Want It Weakened

<![CDATA[TrumpRx Expands to Offer Generic Medications]]>

<![CDATA[The Gates Foundation: Perfectly Aligned Interests]]>

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

Pharma's Deal Boom Is Fueling Demand for M&A Lawyers

Many large pharmaceutical companies are increasingly turning to acquisitions rather than relying solely on internal research and development efforts to build their drug pipelines....

<![CDATA[Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals ]]>

US Investments Intended To Take Indian Pharma Up The Value Chain: Interview

This is the first time such huge investments are being made. The Indian pharmaceutical industry has grown from small companies into multinational corporations. Out of the top 20 gl...

<![CDATA[Rethinking Pharma's Go-to-Market Formula]]>

Amazon Just Put the Biggest Trade of the Decade on the Wrong Side—and Big Pharma Is Paying for It

Amazon’s new GLP-1 pricing is dragging Novo Nordisk and Eli Lilly stocks lower.

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

Top 10 Pharmaceutical Sectors Set to Boom (2026–2031)

The pharmaceutical industry is entering a new era of hyper-growth, specifically within subsectors powered by next-generation biological and genetic engineering. These fields are cu...

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

<![CDATA[What Pharma Investors Should Expect in the Current Regulatory Environment]]>

<![CDATA[Capital Gains]]>

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics]]>

<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>

<![CDATA[Maximizing Drug Impact]]>